business
FDA to Review Easing Restrictions on Peptides
This summer the FDA will consider loosening restrictions on certain peptide injections, with encouragement from RFK Jr. and the Trump administration. Bloomberg Businessweek senior reporter Amanda Mull explains to hosts David Gura and Christina Ruffini how peptides are popular among wellness enthusia
Read full story on Bloomberg Markets → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop